AS-026
Ref. Standard
99.3%
HPLC Verified Purity
Weight Management
Tirzepatide
A dual GIP and GLP-1 receptor agonist extensively studied in laboratory and animal models for appetite signaling, insulin-response pathways, lipid-metabolism markers, and glucose homeostasis. For laboratory and scientific research purposes only.
Available sizes
Quality & Verification
HPLC ≥ 99.3%
Purity Verified
Mass Spec
Identity Confirmed
Endotoxin
< 0.1 EU/µg
Lyophilized
Sealed Under Vacuum
Molecular Reference
In-Vitro
- Formula
- C225H348N48O68
- Molecular Weight
- 4,813.53 g/mol
- Amino Acids
- 39
- CAS Number
- 2023788-19-2
Reconstitution Reference
mg/mL
Concentration output for laboratory reference handling. Not dosing guidance.
Concentration
5.00
mg / mL
Concentration
5000
µg / mL
For laboratory and scientific research purposes only. Not for human or animal consumption. This calculator does not provide dosing, protocol, or administration guidance.
Selected Literature
Full Library →- Tirzepatide once weekly for the treatment of obesityJastreboff AM, et al. · N Engl J Med · 2022 · PMID 35658024
- Dual GIP and GLP-1 receptor agonism in type 2 diabetesFrías JP, et al. · Lancet · 2021 · PMID 34186022
Related in Weight Management
AS-026 · 10mg
$99